Search

Your search keyword '"Teranishi, Jun-ichi"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Teranishi, Jun-ichi" Remove constraint Author: "Teranishi, Jun-ichi" Database Unpaywall Remove constraint Database: Unpaywall
73 results on '"Teranishi, Jun-ichi"'

Search Results

2. Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma

6. Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

8. Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib

9. High orchiectomy and ipsilateral testicular sperm extraction in a man with a testicular tumor and Klinefelter syndrome: A case report

10. PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer

13. Prostate Basal Cell Carcinoma: A Case Report

14. FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma

17. Adrenal Hemangioma: A Case of Retroperitoneal Tumor

19. Management of urethral stricture: High‐pressure balloon dilation versus optical internal urethrotomy

20. Paraganglioma in the bladder: a case report

21. Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer

22. A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy

24. Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate

28. Onco-testicular sperm extraction (onco-TESE) for bilateral testicular tumors: two case reports

29. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival

30. The usefullness of low-molecular-weight protein tyrosine phosphatase as a prognostic factor in metastatic hormone-sensitive prostate cancer.

31. Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy

32. A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

33. The neutrophil-to-lymphocyte ratio is an effective prognostic marker in localized upper urinary tract urothelial carcinoma treated with nephroureterectomy

34. Xanthogranulomatous Pyelonephritis with Incomplete Double Ureter

36. RANK/RANKL expression in prostate cancer

37. Foreign body in the bladder: A case report

38. Ductal Adenocarcinoma of the Prostate: A Case Report

39. Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer

40. Inflammatory Myofibroblastic Tumor in the Bladder: A Case Report

41. Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer

42. Epidermal Cyst in the Scrotum Successfully Treated while Preserving the Testis: A Case Report

43. Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report

44. Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases

46. Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer

47. Predictive value of bone scan index using computer-aided diagnosis system for bone scans in patients receiving first-line hormone therapy for metastatic hormone-sensitive prostate cancer.

48. Identification of a predictive factor of metastatic castration-resistant prostate cancer patients’ response to alternative antiandrogen therapy with flutamide.

50. Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Catalog

Books, media, physical & digital resources